Siemens Atellica DCA™ HbA1c Dx - HSA Registration DE0507575
Access comprehensive regulatory information for Siemens Atellica DCA™ HbA1c Dx in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0507575 and owned by Simens Healthcare Diagnostics Inc.. The device was registered on December 06, 2022.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Atellica DCA HbA1c assay is an in vitro diagnostic test for quantitative determination of mmol/mol of Hemoglobin A1c (HbA1c) (IFCC) and % HbA1c (DCCT/NGSP) in human venous and capillary whole blood. This test is to be used as an aid in the diagnosis of diabetes and as an aid in identifying patients who may be at risk for developing diabetes. The measurement of HbA1c is recommended as a marker of long-term metabolic control in persons with diabetes mellitus.